5 Narcolepsy Type 1 Clinical Trials in Miami, FL (2026)

Q: How do I join a clinical trial in Miami?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you.

Recruiting Narcolepsy Type 1 Studies in Miami

NCT07598708Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Narcolepsy Type 1 (NT1) and Narcolepsy Type 2 (NT2) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with...

Miami, FLPHASE2222 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT07455383Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

The purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared wi...

Miami, FLPHASE3150 participantsAlkermes, Inc.

View Study Details

NCT07540897Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

Miami, FLPHASE3150 participantsAlkermes, Inc.

View Study Details

NCT07633301Recruiting

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Narcolepsy is a sleep disorder that disrupts a person's regular sleep-wake cycle. It causes extreme sleepiness during the day (called excessive daytime sleepiness \[EDS\]), where a person may fall asl...

Miami, FLPHASE292 participantsTakeda

View Study Details

NCT07096674Recruiting

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT...

Miami, FLPHASE290 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

About Narcolepsy Type 1 Clinical Trials in Miami

Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.

There are currently 5 narcolepsy type 1 clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 704 participants. Research is being sponsored by Centessa Pharmaceuticals (UK) Limited, Alkermes, Inc., Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.

Narcolepsy Type 1 Clinical Trials in Miami — FAQ

Are there narcolepsy type 1 clinical trials in Miami?

Yes, there are 5 narcolepsy type 1 clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What narcolepsy type 1 treatments are being tested?

The 5 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.

Data updated October 15, 2026 from ClinicalTrials.gov